Latest Boardroom Shifts News

Page 34 of 170
Arovella Therapeutics reported a 22% increase in half-year losses to $1.88 million while securing FDA acceptance of its IND application for lead asset ALA-101, paving the way for first-in-human trials.
Ada Torres
Ada Torres
19 Feb 2026
Adrad Holdings reported a modest revenue rise and a dip in statutory profit for the half-year ending December 2025, while its Heat Transfer Solutions segment showed robust growth. The company declared a fully franked interim dividend, reflecting confidence amid ongoing restructuring.
Victor Sage
Victor Sage
19 Feb 2026
Enero Group’s half-year results reveal a 6.3% revenue decline but a striking 119% surge in adjusted profit, alongside strategic leadership changes and a steady dividend.
Victor Sage
Victor Sage
19 Feb 2026
IPH Limited reported a solid half-year performance with revenue up 6.5% to $363.9 million and net profit rising 10.5% to $41.2 million, driven by strong gains in Canada and Asia despite a decline in Australia and New Zealand.
Victor Sage
Victor Sage
19 Feb 2026
Ventia Services Group Limited reported a 23.6% increase in profit after tax for FY25 to $272.2 million, alongside record contract wins and a strong sustainability agenda. The company declared a 12.54 cents per share final dividend, underscoring its commitment to shareholder returns and operational excellence.
Victor Sage
Victor Sage
19 Feb 2026
Nyrada Inc. reported a $3.19 million loss for the half-year ending December 2025, while advancing its lead drug candidate Xolatryp® into Phase IIa clinical trials targeting heart attack treatment.
Ada Torres
Ada Torres
18 Feb 2026
IDT Australia reports a robust 20.3% increase in core revenue and a dramatic narrowing of EBITDA losses, signalling early success from its strategic realignment under new leadership.
Victor Sage
Victor Sage
18 Feb 2026
TechnologyOne has upgraded its FY26 profit and recurring revenue growth forecasts, citing strong confidence in AI-enhanced SaaS+ products and a robust customer pipeline across key markets.
Sophie Babbage
Sophie Babbage
18 Feb 2026
INOVIQ Limited reported a $3.96 million net loss for H1 2026, driven by increased R&D spend, while securing $10.2 million to accelerate its exosome-based cancer diagnostics and therapeutics pipeline.
Ada Torres
Ada Torres
18 Feb 2026
Celsius Resources has appointed Peter Hume as interim chairman while progressing the sale of its Opuwo project and reclaiming a key 60% shareholding in its Philippine affiliate after funding obligations were unmet.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Cauldron Energy has announced a major uranium resource upgrade at its Yanrey Project in Western Australia, now exceeding 55 million pounds of uranium oxide. Backed by strong project economics and fully funded drilling for 2026, the company is poised to capitalise on the global nuclear resurgence amid ongoing policy challenges.
Maxwell Dee
Maxwell Dee
17 Feb 2026
AMCIL and AFIC announce a major leadership transition as long-serving CEO Mark Freeman retires, with Alison Gibson appointed to succeed him in July 2026.
Claire Turing
Claire Turing
17 Feb 2026